Probability of survival following treatment with GO without IL-11, GO with IL-11, or IA.

Kaplan-Meier estimates of the proportion of patients remaining alive from start of treatment (P = .03 on log-rank test). Sixteen of the 26 patients given GO without IL-11, 13 of the 25 given GO with IL-11, and 16 of the 31 given IA have died. Median censoring times were 14 weeks for GO without IL-11, 17 weeks for GO with IL-11, and 10 weeks for IA.